These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 14749153

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.
    Motheral B, Fairman KA.
    Med Care; 2001 Dec; 39(12):1293-304. PubMed ID: 11717571
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect on drug utilization and expenditures of a cost-share change from copayment to coinsurance.
    Klepser DG, Huether JR, Handke LJ, Williams CE.
    J Manag Care Pharm; 2007 Dec; 13(9):765-77. PubMed ID: 18062728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.
    Yeung K, Basu A, Hansen RN, Watkins JB, Sullivan SD.
    Med Care; 2017 Feb; 55(2):191-198. PubMed ID: 27579915
    [Abstract] [Full Text] [Related]

  • 10. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF, Escarce JJ, Solomon MD, Goldman DP.
    JAMA; 2002 Oct 09; 288(14):1733-9. PubMed ID: 12365957
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E, Kyrychenko P, Matlin OS, Avila JP, Brennan TA, Shrank WH.
    J Clin Pharm Ther; 2016 Feb 09; 41(1):64-9. PubMed ID: 26778812
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013.
    Brouwer ED, Basu A, Yeung K.
    Pharmacoeconomics; 2019 Oct 09; 37(10):1287-1300. PubMed ID: 31270747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Controlling prescription drug expenditures: a report of success.
    Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA.
    Am J Manag Care; 2007 Aug 09; 13(8):473-80. PubMed ID: 17685828
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.